Chimerix Inc (CMRX)
0.9068
-0.01
(-0.76%)
USD |
NASDAQ |
Nov 22, 16:00
0.9068
0.00 (0.00%)
After-Hours: 16:13
Chimerix Revenue (Quarterly): 0.026M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.026M |
| June 30, 2024 | 0.129M |
| March 31, 2024 | |
| December 31, 2023 | 0.004M |
| September 30, 2023 | 0.011M |
| June 30, 2023 | 0.026M |
| March 31, 2023 | 0.283M |
| December 31, 2022 | 0.814M |
| September 30, 2022 | 32.56M |
| June 30, 2022 | 0.44M |
| March 31, 2022 | 0.015M |
| December 31, 2021 | 0.046M |
| September 30, 2021 | 0.107M |
| June 30, 2021 | 0.391M |
| March 31, 2021 | 1.435M |
| December 31, 2020 | 1.12M |
| September 30, 2020 | 1.609M |
| June 30, 2020 | 1.402M |
| March 31, 2020 | 1.241M |
| December 31, 2019 | 6.767M |
| September 30, 2019 | 1.958M |
| June 30, 2019 | 1.438M |
| March 31, 2019 | 2.356M |
| December 31, 2018 | 4.864M |
| September 30, 2018 | 0.369M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.193M |
| March 31, 2018 | 0.79M |
| December 31, 2017 | 1.844M |
| September 30, 2017 | 0.897M |
| June 30, 2017 | 0.675M |
| March 31, 2017 | 1.078M |
| December 31, 2016 | 1.98M |
| September 30, 2016 | 0.653M |
| June 30, 2016 | 1.841M |
| March 31, 2016 | 1.228M |
| December 31, 2015 | 3.11M |
| September 30, 2015 | 2.271M |
| June 30, 2015 | 4.143M |
| March 31, 2015 | 1.238M |
| December 31, 2014 | 1.156M |
| September 30, 2014 | 1.185M |
| June 30, 2014 | 0.919M |
| March 31, 2014 | 0.78M |
| December 31, 2013 | 0.879M |
| September 30, 2013 | 0.912M |
| June 30, 2013 | 0.808M |
| March 31, 2013 | 1.771M |
| December 31, 2012 | 3.581M |
| September 30, 2012 | 20.86M |
| June 30, 2012 | 6.205M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.004M
Minimum
Dec 2023
32.56M
Maximum
Sep 2022
2.548M
Average
0.391M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 283.80M |
| SIGA Technologies Inc | 10.01M |
| Tonix Pharmaceuticals Holding Corp | 2.822M |
| Geovax Labs Inc | 2.790M |
| Lyell Immunopharma Inc | 0.034M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.88M |
| Total Expenses (Quarterly) | 24.82M |
| EPS Diluted (Quarterly) | -0.26 |
| Enterprise Value | -54.06M |
| Profit Margin (Quarterly) | -88.00K% |
| Earnings Yield | -104.8% |
| Normalized Earnings Yield | -104.76 |